Related Experiment Videos

The effects of fibrates on lipoprotein and hemostatic coronary risk factors

G Schonfeld1

  • 1Div. Atherosclerosis, Nutrition and Lipid Research, Washington University School of Medicine, St. Louis, Missouri 63110.

Atherosclerosis
|December 1, 1994
PubMed

Insights

Fibrates improve lipoprotein profiles and affect coagulation and fibrinolysis, suggesting benefits for preventing atherosclerosis. These lipid-lowering drugs offer a promising therapeutic strategy for cardiovascular health.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Atherosclerosis is a major cause of cardiovascular disease.
  • Lipoprotein profiles and coagulation/fibrinolysis factors are key determinants of atherosclerosis.
  • Fibrates are a class of drugs known to affect lipid metabolism.

Purpose of the Study:

  • To review the effects of fibrates on lipoprotein profiles.
  • To examine the impact of fibrates on lipoprotein physiology.
  • To assess the influence of fibrates on coagulation and fibrinolytic factors relevant to atherosclerosis.

Main Methods:

  • Literature review of studies on fibrate effects.
  • Analysis of data on changes in lipoprotein levels (e.g., HDL, LDL, triglycerides).
  • Evaluation of studies investigating fibrate impact on clotting and clot-dissolving factors.

Main Results:

  • Fibrates significantly alter lipoprotein profiles, often increasing HDL and decreasing triglycerides.
  • Changes in lipoprotein physiology indicate improved lipid handling.
  • Modulation of selected coagulation and fibrinolytic factors suggests an antithrombotic effect.

Conclusions:

  • Fibrates demonstrate beneficial effects on multiple systems implicated in atherosclerosis.
  • The combined actions on lipoproteins and hemostasis support fibrates' role in atherosclerosis prevention.
  • Fibrates represent a valuable therapeutic option for managing cardiovascular risk.

Related Concept Videos